Amir Lahav

Amir is a Digital Health Advisor and Board Member for Pharma and Medtech companies. He is also the Founder and CEO of SkyMed Digital.

With over 20 years of clinical experience, Amir is on a mission to bring together the brightest minds from far-ranging disciplines to push the boundaries of AI-driven solutions in clinical research and medicine.

During his time at Pfizer, Amir led the development of digital solutions for gene therapy trials, primarily in rare diseases. Prior to pharma, Amir was a Principal Investigator on numerous clinical trials as a Neurology Faculty and Professor of Pediatrics at Harvard Medical School.

His unique combination of clinical expertise and digital health innovation makes him an invaluable advisor to Videra Health's pharmaceutical and life sciences initiatives.